Discovery of 4-methyl-N-(4-((4-methylpiperazin- 1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-oxy)benzamide as a potent inhibitor of RET and its gatekeeper mutant.
Eur J Med Chem
; 207: 112755, 2020 Dec 01.
Article
in En
| MEDLINE
| ID: mdl-32882611
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Drug Design
/
Protein Kinase Inhibitors
/
Proto-Oncogene Proteins c-ret
/
Mutation
Limits:
Humans
Language:
En
Journal:
Eur J Med Chem
Year:
2020
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
France